跳至主要内容
临床试验/NCT04640415
NCT04640415已完成不适用

Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration vs. Routine Monitoring of High-risk Patients After Major Surgery. A Randomized Controlled Trial.

Rigshospitalet, Denmark4 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2021年1月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
400
试验地点
4
主要终点
Cumulative duration

研究概览

简要总结

The primary aim of the current study is to assess the effect of continuous wireless vital sign monitoring with generation of real-time alerts, compared to blinded monitoring without alerts on the cumulative duration of any severely deviating vital signs in patients admitted to general hospital wards after major surgery.

We hypothesize that continuous vital signs monitoring, and real-time alerts will reduce the cumulative duration of severely deviating vital signs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admission for acute or elective major abdominal (laparotomy/laparoscopy), major orthopedic, major urologic, or arterial vascular surgery.
  • Estimated duration of surgery ≥2 hours and at least two expected overnight stays.
  • Randomization and commencement of continuous wireless monitoring possible within 24 hours postoperatively

排除标准

  • Patient expected not to cooperate with study procedures.
  • Allergy to plaster or silicone.
  • Impaired cognitive function (in uncertain cases assessed by a Mini Mental State Examination] score < 24)
  • Patients admitted for palliative care only (i.e. no active treatment).
  • Planned admission to unit using continuous vital sign monitoring (i.e. an intermediary care/telemetry unit).
  • Patients previously enrolled in the medical WARD RCT.
  • Patients with a pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
  • Inability to give informed consent.

结局指标

主要结局

Cumulative duration

时间窗: During monitoring, for a maximum of up to 5 postoperative days or until discharge.

Cumulative duration of one or more deviations in vital signs. List of vital signs, and normal limits detailed in protocol.

次要结局

  • Frequency of sustained deviation alerts(During monitoring, for a maximum of up to 5 postoperative days or until discharge.)
  • Any adverse event(7 days and 30 days after start of monitoring)
  • Any serious adverse event(7 days and 30 days after start of monitoring)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jesper Mølgaard

MD, Ph.d student

Rigshospitalet, Denmark

研究点 (4)

Loading locations...

相似试验

Continuous Wireless Monitoring of Vital Signs and... | 临床试验